background logo image

Episode 202

Is The Egg Debate Finally Over? See what a New Dementia Study Says.

Listen, Watch & Subscribe on:

Watch

Is The Egg Debate Finally Over? See what a New Dementia Study Says.

Listen

About the host

Bret Scher, MD

Bret Scher, MD

Medical Director, Metabolic Mind and Baszucki Group

Bret is the host of the Metabolic Mind YouTube channel and podcast. He is a board-certified cardiologist, lipidologist, and leading expert in therapeutic uses of metabolic therapies, including ketogenic diets. Prior to joining Baszucki Group, Bret was the medical director at DietDoctor.com, an online platform promoting improving metabolic health through low-carb nutrition, where he was a content creator and medical reviewer. Earlier in his career, he worked as a cardiologist in San Diego. Bret has spent most of his 20-year career as a preventive cardiologist, helping people improve their metabolic health and preventing heart disease using low-carb nutrition and lifestyle interventions. His deep passion for educating the public about the benefits of metabolic therapies grew from his experience with the prevailing medical teaching, which frequently misrepresents nutrition science and undervalues metabolic health. Bret received an MD from The Ohio State University College of Medicine and a BS in Biology from Stanford University. He grew up in San Diego and began competing in triathlons at an early age, which helped fuel his love of health and fitness. He continues to enjoy spending time outdoors mountain biking, swimming, hiking, and playing baseball with his two boys.
Learn more about Bret

Bret Scher, MD

Medical Director, Metabolic Mind and Baszucki Group

Bret is the host of the Metabolic Mind YouTube channel and podcast. He is a board-certified cardiologist, lipidologist, and leading expert in therapeutic uses of metabolic therapies, including ketogenic diets. Prior to joining Baszucki Group, Bret was the medical director at DietDoctor.com, an online platform promoting improving metabolic health through low-carb nutrition, where he was a content creator and medical reviewer. Earlier in his career, he worked as a cardiologist in San Diego. Bret has spent most of his 20-year career as a preventive cardiologist, helping people improve their metabolic health and preventing heart disease using low-carb nutrition and lifestyle interventions. His deep passion for educating the public about the benefits of metabolic therapies grew from his experience with the prevailing medical teaching, which frequently misrepresents nutrition science and undervalues metabolic health. Bret received an MD from The Ohio State University College of Medicine and a BS in Biology from Stanford University. He grew up in San Diego and began competing in triathlons at an early age, which helped fuel his love of health and fitness. He continues to enjoy spending time outdoors mountain biking, swimming, hiking, and playing baseball with his two boys.
Learn more about Bret

Key Highlights

  • A new observational study found higher egg consumption associated with lower dementia risk, but as an observational study, it can only show a pattern, not prove that eggs prevent dementia.
  • The group eating the fewest eggs was actually healthier at baseline, exercising more, smoking less, and having a lower BMI, yet they didn’t show a dementia advantage over higher egg eaters, which weakens the case that eggs are harmful.
  • The study was partly funded by the National Egg Board but also by the National Cancer Institute, a body with no financial stake in eggs, and the episode notes no major methodological red flags beyond typical observational study limitations.
  • The historical case against eggs, based on dietary cholesterol raising blood cholesterol and heart disease risk, doesn’t hold up well, since dietary cholesterol has a modest effect on blood cholesterol for most people and eggs can raise HDL while lowering triglycerides.
  • Eggs are highlighted as a nutrient-dense whole food, offering complete protein, high leucine content, and choline important for brain health, reinforcing the case that outdated advice to avoid eggs isn’t well supported by evidence.

Transcript

Listen, Watch & Subscribe on:

You May Also Be Interested In:

The Alzheimer’s Antidote, by Amy Berger
Resources

The Alzheimer’s Antidote, by Amy Berger

Amy Berger’s research shows that Alzheimer’s results from a fuel shortage in the brain.

Read more

Research Shows Eating THIS Could Reduce Alzheimer’s Risk
Podcast

Research Shows Eating THIS Could Reduce Alzheimer’s Risk

On this episode, Dr. Bret Scher explores what the latest research says about ApoE4, diet, and dementia risk. Despite longstanding recommendations for ApoE4 carriers to limit red meat, emerging data challenges that assumption and raises new questions about how nutrition, metabolic health, and lifestyle may interact with genetic risk for Alzheimer’s disease.

Learn more

What Do Adenosine, Forests & Keto Diets Have to do with Brain Health?
Podcast

What Do Adenosine, Forests & Keto Diets Have to do with Brain Health?

Dr. Bret Scher talks with neuroscientist Dr. Susan Masino about why ketogenic therapy isn’t a single-mechanism “drug” but a multi-pathway approach that can stabilize brain networks and support long-term resilience. Masino’s research centers on adenosine—an energy- and signaling molecule that rises with ketone metabolism and helps suppress seizures, modulate neural activity, and drive epigenetic changes. She introduces “preconditioning,” showing how ketosis can ready the brain to better withstand future insults such as stroke, with adenosine as a key mediator. Beyond diet, Masino bridges neuroscience with her forestry work, summarizing evidence that regular exposure to nature lowers anxiety and loneliness and should be treated as a practical, community-level tool for mental health. The conversation reframes brain care around prevention: combine ketogenic strategies, time in nature, and other lifestyle supports to build durable mental well-being—while working with clinicians for safe, individualized implementation.

Learn more

New Alzheimer’s Trial Reveals Surprising Insight on Brain Health
Podcast

New Alzheimer’s Trial Reveals Surprising Insight on Brain Health

A new clinical trial reveals semaglutide does not improve cognition in Alzheimer’s disease, challenging earlier observational findings. This highlights the complexity of dementia and suggests metabolic improvements from drugs alone may not be enough. Emerging research points to ketogenic therapy as a promising approach, offering the brain an alternative fuel source when glucose metabolism is impaired.

Learn more

The Alzheimer’s Antidote, by Amy Berger
Resources

The Alzheimer’s Antidote, by Amy Berger

Amy Berger’s research shows that Alzheimer’s results from a fuel shortage in the brain.

Read more

Research Shows Eating THIS Could Reduce Alzheimer’s Risk
Podcast

Research Shows Eating THIS Could Reduce Alzheimer’s Risk

On this episode, Dr. Bret Scher explores what the latest research says about ApoE4, diet, and dementia risk. Despite longstanding recommendations for ApoE4 carriers to limit red meat, emerging data challenges that assumption and raises new questions about how nutrition, metabolic health, and lifestyle may interact with genetic risk for Alzheimer’s disease.

Learn more

What Do Adenosine, Forests & Keto Diets Have to do with Brain Health?
Podcast

What Do Adenosine, Forests & Keto Diets Have to do with Brain Health?

Dr. Bret Scher talks with neuroscientist Dr. Susan Masino about why ketogenic therapy isn’t a single-mechanism “drug” but a multi-pathway approach that can stabilize brain networks and support long-term resilience. Masino’s research centers on adenosine—an energy- and signaling molecule that rises with ketone metabolism and helps suppress seizures, modulate neural activity, and drive epigenetic changes. She introduces “preconditioning,” showing how ketosis can ready the brain to better withstand future insults such as stroke, with adenosine as a key mediator. Beyond diet, Masino bridges neuroscience with her forestry work, summarizing evidence that regular exposure to nature lowers anxiety and loneliness and should be treated as a practical, community-level tool for mental health. The conversation reframes brain care around prevention: combine ketogenic strategies, time in nature, and other lifestyle supports to build durable mental well-being—while working with clinicians for safe, individualized implementation.

Learn more

New Alzheimer’s Trial Reveals Surprising Insight on Brain Health
Podcast

New Alzheimer’s Trial Reveals Surprising Insight on Brain Health

A new clinical trial reveals semaglutide does not improve cognition in Alzheimer’s disease, challenging earlier observational findings. This highlights the complexity of dementia and suggests metabolic improvements from drugs alone may not be enough. Emerging research points to ketogenic therapy as a promising approach, offering the brain an alternative fuel source when glucose metabolism is impaired.

Learn more